These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 31880080)

  • 1. Active Targeting of Dendritic Polyglycerols for Diagnostic Cancer Imaging.
    Pant K; Neuber C; Zarschler K; Wodtke J; Meister S; Haag R; Pietzsch J; Stephan H
    Small; 2020 Feb; 16(7):e1905013. PubMed ID: 31880080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of surface charge on serum protein interaction and cellular uptake: studies with dendritic polyglycerols and dendritic polyglycerol-coated gold nanoparticles.
    Bewersdorff T; Vonnemann J; Kanik A; Haag R; Haase A
    Int J Nanomedicine; 2017; 12():2001-2019. PubMed ID: 28352171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ⁹⁹mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study.
    Li C; Wen B; Wang L; Feng H; Xia X; Ding Z; Gao B; Zhang Y; Lan X
    Nucl Med Commun; 2015 May; 36(5):452-60. PubMed ID: 25591074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
    Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
    J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation.
    Zhou Z; Vaidyanathan G; McDougald D; Kang CM; Balyasnikova I; Devoogdt N; Ta AN; McNaughton BR; Zalutsky MR
    Mol Imaging Biol; 2017 Dec; 19(6):867-877. PubMed ID: 28409338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies.
    Zarschler K; Prapainop K; Mahon E; Rocks L; Bramini M; Kelly PM; Stephan H; Dawson KA
    Nanoscale; 2014 Jun; 6(11):6046-56. PubMed ID: 24777583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zwitterionic near-infrared fluorophore-conjugated epidermal growth factor for fast, real-time, and target-cell-specific cancer imaging.
    Kim H; Cho MH; Choi HS; Lee BI; Choi Y
    Theranostics; 2019; 9(4):1085-1095. PubMed ID: 30867817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering the Orientation, Density, and Flexibility of Single-Domain Antibodies on Nanoparticles To Improve Cell Targeting.
    Yong KW; Yuen D; Chen MZ; Johnston APR
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5593-5600. PubMed ID: 31917547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Uniform Synthesis of Selenium Nanoparticles with EGFR Targeting and Tumor Microenvironment-Responsive Ability for Simultaneous Diagnosis and Therapy of Nasopharyngeal Carcinoma.
    Huang J; Huang W; Zhang Z; Lin X; Lin H; Peng L; Chen T
    ACS Appl Mater Interfaces; 2019 Mar; 11(12):11177-11193. PubMed ID: 30821437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand.
    Mickler FM; Möckl L; Ruthardt N; Ogris M; Wagner E; Bräuchle C
    Nano Lett; 2012 Jul; 12(7):3417-23. PubMed ID: 22632479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface charge and particle size determine the metabolic fate of dendritic polyglycerols.
    Pant K; Pufe J; Zarschler K; Bergmann R; Steinbach J; Reimann S; Haag R; Pietzsch J; Stephan H
    Nanoscale; 2017 Jun; 9(25):8723-8739. PubMed ID: 28616954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents.
    Nordmeyer D; Stumpf P; Gröger D; Hofmann A; Enders S; Riese SB; Dernedde J; Taupitz M; Rauch U; Haag R; Rühl E; Graf C
    Nanoscale; 2014 Aug; 6(16):9646-54. PubMed ID: 24991655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of [64Cu]Cu-NOTA-Bn-GE11 for PET imaging of EGFR-rich tumors.
    Dejesus OT
    Curr Radiopharm; 2012 Jan; 5(1):15-8. PubMed ID: 21864245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (99m) Tc-labeled tetramer and pentamer of single-domain antibody for targeting epidermal growth factor receptor in xenografted tumors.
    Li C; Feng H; Xia X; Wang L; Gao B; Zhang Y; Lan X
    J Labelled Comp Radiopharm; 2016 Jun; 59(8):305-12. PubMed ID: 27123559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
    Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
    Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.
    Miao Z; Ren G; Liu H; Jiang L; Cheng Z
    J Biomed Opt; 2010; 15(3):036007. PubMed ID: 20615009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pointing in the Right Direction: Controlling the Orientation of Proteins on Nanoparticles Improves Targeting Efficiency.
    Yong KW; Yuen D; Chen MZ; Porter CJH; Johnston APR
    Nano Lett; 2019 Mar; 19(3):1827-1831. PubMed ID: 30773887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer.
    Wang Z; Qiao R; Tang N; Lu Z; Wang H; Zhang Z; Xue X; Huang Z; Zhang S; Zhang G; Li Y
    Biomaterials; 2017 May; 127():25-35. PubMed ID: 28279919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the targeting of therapeutics with single-domain antibodies.
    Turner KB; Alves NJ; Medintz IL; Walper SA
    Expert Opin Drug Deliv; 2016; 13(4):561-70. PubMed ID: 26689649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.